CD19 and acute lymphoblastic leukemia: 33-3-19 was added to cytolysis reactions of unstimulated mononuclear cells (MNCs) from healthy donors, which were mixed with SEM (CD19-positive pre-B ALL cell line) target cells at an effector-to-target (E : T) ratio of 1 : 2.